India has achieved the elimination of leprosy as a public health problem (i.e., less than 1 case per 10,000 population at the national level in 2005), as per WHO criteria. However, the persistence of the disease in certain states and districts has necessitated a more targeted approach to achieving zero transmission by 2027. The Union Health Ministry's National Strategic Plan (NSP) and Roadmap for Leprosy (2023-27) aims to achieve this goal through early detection, targeted interventions, and awareness campaigns.

1. Understanding Leprosy: Causes and Challenges

A. What is Leprosy?

• Leprosy is a chronic infectious disease caused by the Mycobacterium leprae bacterium.
• It primarily affects the skin, peripheral nerves, respiratory tract, and eyes, leading to disabilities if untreated.
• It is classified as a Neglected Tropical Disease (NTD) and still occurs in over 120 countries.

B. India's Leprosy Burden

• India continues to report the highest number of leprosy cases globally, with 75,394 new cases in 2021-22, a significant decline from 125,785 in 2014-15.
• Five states—Bihar, Chhattisgarh, Jharkhand, Maharashtra, and Odisha—account for the highest prevalence of leprosy in India.
• Certain districts within states/UTs remain endemic despite national-level elimination.

2. National Strategic Plan (NSP) and Roadmap for Leprosy (2023-27)

A. Objectives of NSP (2023-27)

• Achieve zero transmission of leprosy by 2027, three years ahead of the Sustainable Development Goals (SDGs) target (2030).
• Encourage early case detection to prevent Grade 2 Disabilities (permanent disabilities due to late diagnosis).
• Ensure free-of-cost treatment under the National Leprosy Eradication Programme (NLEP).
• Reduce stigma and discrimination associated with the disease.

B. Key Interventions Under NSP (2023-27)

1. Improved Treatment Regimen

• Introduction of a three-drug regimen for Pauci-Bacillary (PB) cases instead of the previous two-drug regimen, ensuring better treatment outcomes.

2. Awareness and Stigma Reduction

• Nationwide campaigns to reduce social discrimination against leprosy patients.
• Community-based programs to improve early case detection and reduce social exclusion.

3. Strengthening Surveillance and Reporting

• Deployment of Nikusth 2.0, a web-based information portal for real-time reporting of leprosy cases.
• District-level monitoring mechanisms to track progress in endemic areas.

4. Prevention of Disease Transmission

• Leprosy Post-Exposure Prophylaxis (LPEP)—providing preventive treatment to close contacts of leprosy patients.
• Strengthening primary healthcare centers (PHCs) and ASHA workers’ involvement in community-based detection.

3. Global Leprosy Trends and India’s Position

A. Global Scenario

• The WHO declared leprosy eliminated as a public health problem globally in 2000, but transmission persists in some countries.
• India, Brazil, and Indonesia report over 10,000 new cases annually.
• Other high-burden countries include Bangladesh, Myanmar, Nepal, Nigeria, Philippines, Sri Lanka, and Somalia (reporting 1,000–10,000 cases each).

B. India’s Role in Global Leprosy Eradication

• India accounts for 53.6% of global new leprosy cases, making it a critical country in WHO’s global elimination strategy.
• Success in India’s targeted containment strategy will have global implications for leprosy eradication.

4. Challenges in Eliminating Leprosy in India

A. Hidden Burden in Rural and Tribal Areas

• Many cases go unreported due to lack of awareness and stigma, particularly in rural areas.
• Certain tribal and economically backward districts continue to have higher case prevalence.

B. Social Stigma and Discrimination

• Leprosy patients face exclusion, job loss, and societal rejection, leading to delayed diagnosis and treatment.
• Myths and misinformation about leprosy persist despite medical advancements.

C. Treatment Gaps and Drug Resistance

• Multi-drug therapy (MDT) is effective, but delayed diagnosis leads to disabilities.
• Some resistance to leprosy drugs has been observed, requiring constant monitoring and research.

D. Health Infrastructure and Manpower Shortages

• Many primary health centers (PHCs) lack trained medical personnel for leprosy diagnosis and treatment.
• Need for specialized rehabilitation centers for patients with Grade 2 disabilities.

5. Way Forward: Strategies to Achieve Zero Leprosy Transmission by 2027

A. Strengthening Early Detection and Community Engagement

• Expanding door-to-door surveys and screening programs in high-prevalence states.
• Increasing ASHA worker training to improve case detection at the grassroots level.

B. Combating Stigma Through Awareness Campaigns

• Nationwide media campaigns to educate the public about leprosy’s curability and non-contagious nature after treatment.
• Legislative action to remove discriminatory laws against leprosy patients.

C. Enhancing Medical and Research Interventions

• Expanding availability of free MDT treatment in all government hospitals.
• Investing in research on new drug regimens and vaccines to prevent transmission.

D. Strengthening Surveillance and Digital Reporting

• Expanding Nikusth 2.0 portal for better tracking and mapping of new cases.
• Integrating leprosy detection into routine health checkups at PHCs and district hospitals.

6. Conclusion

India’s targeted approach under the National Strategic Plan (2023-27) aims to completely stop leprosy transmission by 2027, three years ahead of the SDG target (2030). While significant progress has been made in reducing cases, challenges such as social stigma, hidden prevalence, and drug resistance need urgent attention. Through early detection, awareness programs, and strengthened surveillance, India has the potential to lead global efforts in eradicating leprosy.

"Leprosy elimination is not just a medical challenge but also a social and economic issue." Examine the role of stigma, discrimination, and public awareness in leprosy eradication efforts in India. (250 words)

Leprosy, caused by Mycobacterium leprae, is not just a medical condition but also a social and economic challenge in India. Despite achieving national-level elimination (less than 1 case per 10,000 population in 2005), the disease persists due to stigma, discrimination, and lack of awareness. These factors hinder early detection, treatment, and reintegration of affected individuals into society.

Role of Stigma and Discrimination in Leprosy Eradication

1.   Social Exclusion:

o    Leprosy patients often face ostracization, particularly in rural areas, leading to delayed diagnosis and treatment.

o    Many are abandoned by families and forced to live in leprosy colonies, reinforcing social isolation.

2.   Legal and Workplace Discrimination:

o    Outdated laws and employment restrictions prevent cured patients from fully reintegrating into society.

o    Fear of losing jobs discourages individuals from seeking treatment.

3.   Gender and Economic Disparities:

o    Women with leprosy face greater stigma, leading to divorce, rejection, and reduced access to healthcare.

o    Economic hardships arise due to job loss, inability to work, and limited government support.

Importance of Public Awareness in Leprosy Eradication

1.   Education and Community Engagement:

o    Awareness campaigns can dispel myths that leprosy is highly contagious or incurable.

o    Training ASHA workers and primary healthcare providers can improve early detection.

2.   Policy Interventions:

o    Nikusth 2.0, a digital tracking system, improves surveillance and case reporting.

o    Strengthening social security schemes can help rehabilitate leprosy patients economically.

Conclusion

While medical interventions like multi-drug therapy (MDT) can cure leprosy, the social and economic barriers must also be addressed. Combating stigma, enforcing anti-discrimination laws, and increasing public awareness are critical to achieving zero transmission of leprosy by 2027.

1. With reference to leprosy in India, consider the following statements:

1.   India officially eliminated leprosy as a public health problem at the national level in 2005.

2.   Leprosy is caused by a viral infection and spreads through contaminated water.

3.   India accounts for more than half of the world's new leprosy cases annually.

Which of the statements given above is/are correct?
A. 1 and 3 only
B. 2 and 3 only
C. 1, 2, and 3
D. 1 only

Answer: A. 1 and 3 only
Explanation:

• Statement 1 is correct – India achieved elimination of leprosy as a public health problem in 2005 (less than 1 case per 10,000 population).
• Statement 2 is incorrect – Leprosy is caused by Mycobacterium leprae, a bacterium, not a virus, and it spreads through prolonged close contact rather than contaminated water.
• Statement 3 is correct – India accounts for more than 50% of global new leprosy cases, making it a major public health challenge.

2. Which of the following measures are included in India's National Strategic Plan (NSP) for Leprosy (2023-27)?

1.   Introduction of a three-drug regimen for Pauci-Bacillary (PB) leprosy cases.

2.   Deployment of Nikusth 2.0, a web-based portal for leprosy case reporting.

3.   Establishment of dedicated leprosy hospitals in every district of India.

Select the correct answer using the codes given below:
A. 1 and 2 only
B. 2 and 3 only
C. 1 and 3 only
D. 1, 2, and 3

Answer: A. 1 and 2 only
Explanation:

• Statement 1 is correct – The three-drug regimen for Pauci-Bacillary (PB) leprosy cases replaces the earlier two-drug regimen, improving treatment effectiveness.
• Statement 2 is correct – Nikusth 2.0, a web-based information portal, helps track and report leprosy cases for better monitoring.
• Statement 3 is incorrect – The NSP does not mandate leprosy hospitals in every district, but rather integrates treatment within existing healthcare facilities.

3. Which of the following are major challenges in eliminating leprosy in India?

1.   High levels of stigma and discrimination against leprosy patients.

2.   Lack of an effective treatment for leprosy.

3.   Hidden cases due to delayed diagnosis, especially in rural and tribal areas.

4.   Limited awareness about early symptoms and availability of free treatment.

Select the correct answer using the codes given below:
A. 1, 3, and 4 only
B. 2 and 3 only
C. 1, 2, and 4 only
D. 1, 2, 3, and 4

Answer: A. 1, 3, and 4 only
Explanation:

• Statement 1 is correct – Social stigma prevents early diagnosis and treatment, leading to long-term disabilities in many cases.
• Statement 2 is incorrect – Leprosy is curable with multi-drug therapy (MDT), which has been available for decades.
• Statement 3 is correct – Many leprosy cases go undiagnosed in rural and tribal areas due to limited healthcare access.
• Statement 4 is correct – Lack of awareness about early symptoms and free MDT treatment delays medical intervention.

4. Which of the following statements about leprosy-related discrimination in India is correct?

A. The Indian Constitution explicitly mentions leprosy as a ground for discrimination.
B. Leprosy was historically a ground for divorce under Indian marriage laws.
C. The National Leprosy Eradication Programme (NLEP) does not focus on stigma reduction.
D. The Right to Education (RTE) Act denies schooling to children affected by leprosy.

Answer: B. Leprosy was historically a ground for divorce under Indian marriage laws.
Explanation:

• Option A is incorrect – The Indian Constitution does not explicitly mention leprosy as a ground for discrimination, but various laws historically discriminated against leprosy patients.
• Option B is correct – Until 2019, leprosy was considered a valid ground for divorce under Hindu, Christian, and other marriage laws. This was removed through legal amendments.
• Option C is incorrect – The National Leprosy Eradication Programme (NLEP) actively works on reducing stigma and discrimination through awareness campaigns.
• Option D is incorrect – The Right to Education (RTE) Act does not deny schooling to children affected by leprosy. However, social stigma often prevents them from attending schools.

5. The introduction of Leprosy Post-Exposure Prophylaxis (LPEP) under India's leprosy eradication program aims to:

A. Provide preventive medication to close contacts of leprosy patients to stop transmission.
B. Replace multi-drug therapy (MDT) with a single-dose treatment for all leprosy cases.
C. Vaccinate all individuals in leprosy-endemic districts to create immunity.
D. Use gene therapy to modify bacterial resistance against antibiotics.

Answer: A. Provide preventive medication to close contacts of leprosy patients to stop transmission.
Explanation:

• LPEP (Leprosy Post-Exposure Prophylaxis) is a preventive treatment strategy that provides a single-dose of rifampicin to people who are in close contact with leprosy patients to reduce transmission risk.
• Option B is incorrect – LPEP does not replace MDT, which remains the standard treatment for diagnosed leprosy cases.
• Option C is incorrect – There is no universal vaccine for leprosy yet; prevention relies on post-exposure prophylaxis and early detection.
• Option D is incorrect – Gene therapy is not currently used in leprosy treatment or prevention.